TriSalus Life Sciences Lowers FY2026 Sales Guidance from $54.000M-$57.000M to $46.000M-$48.000M vs $53.119M Est
Benzinga Newsdesk 12 hours ago
NewsGuidance
TriSalus Life Sciences (NASDAQ:TLSI) lowers FY2026 sales outlook from $54.000 million-$57.000 million to $46.000 million-$48.000 million vs $53.119 million estimate.
TriSalus Life Sciences (NASDAQ:TLSI) lowers FY2026 sales outlook from $54.000 million-$57.000 million to $46.000 million-$48.000 million vs $53.119 million estimate.